间歇性跛行干预围术期并发症低但功能恶化与截肢风险仍存
基于新英格兰血管研究组2003-2018年数据库,分析7051例PVI、2527例腹股沟下旁路和849例腹股沟上旁路治疗间歇性跛行的围术期及1年结局。围术期并发症和死亡率低,但1年后部分患者功能状态恶化,且存在肢体丧失风险,强调谨慎选择患者和知情同意。
要点
- 多节段PVI是跛行最常用干预,但孤立胫动脉PVI和腋动脉流入/胫动脉流出旁路证据有限。
- 围术期并发症低:PVI穿刺点血肿4.9%,腹股沟下旁路心脏并发症3.7%,腹股沟上旁路11.3%。
- 1年后初始无需辅助行走者中2.4%-3.6%需辅助,0.3%-1.3%无法行走,同侧免于再干预/截肢生存81.4%-90.6%。
核心结论
- 跛行干预围术期并发症和死亡率低,但1年时部分患者功能状态恶化且存在肢体丧失风险,需谨慎选择患者、优化内科治疗并充分知情同意。
研究设计与样本
- 回顾性队列研究,查询新英格兰血管研究组数据库(2003-2018年)中因跛行行PVI、腹股沟下旁路和腹股沟上旁路的患者。
- 共纳入7051例PVI、2527例腹股沟下旁路和849例腹股沟上旁路,评估围术期和1年结局。
主要发现
- 治疗节段:髂动脉52.2%,股腘动脉54%,胫动脉5.7%;孤立胫动脉干预占1.7%。
- 腹股沟下旁路最常至腘动脉(81.2%),18.8%至胫动脉目标;腹股沟上旁路主要源自腹主动脉(88.6%),腋动脉10.6%,胸主动脉0.8%。
- 围术期并发症:PVI穿刺点血肿4.9%,腹股沟下旁路心脏并发症3.7%,腹股沟上旁路11.3%;30天死亡率0.4%-2%。
- 1年后初始无需辅助行走者中2.4%-3.6%需辅助,0.3%-1.3%无法行走;同侧免于再干预/截肢生存81.4%-90.6%,免于大截肢生存92.9%-94.1%,生存95.3%-97%。
关键数值与推荐
- 根据SVS指南,任何跛行侵入性治疗必须提供长期获益且并发症风险低。
- 多节段PVI是最常用干预,但孤立胫动脉PVI和腋动脉流入/胫动脉流出旁路证据有限。
临床怎么用
- 临床应谨慎选择跛行干预患者,充分评估功能状态恶化和肢体丧失风险,并进行内科优化和知情同意。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Interventional approaches to managing intermittent claudication vary widely. According to Society for Vascular Surgery guidelines, any invasive treatment of claudication must offer long-term benefit at low risk of complications. Our aim was to evaluate contemporary claudication intervention patterns and functional outcomes. METHODS: The Vascular Study Group of New England database (2003-2018) was queried for peripheral vascular interventions (PVIs), infrainguinal bypasses, and suprainguinal bypasses for claudication. Perioperative and 1-year outcomes were evaluated. RESULTS: There were 7051 PVIs, 2527 infrainguinal bypasses, and 849 suprainguinal bypasses performed for claudication. Treatment levels were iliac (52.2%), femoral-popliteal (54%), and tibial (5.7%). Isolated tibial interventions were completed in 1.7% of patients. Infrainguinal bypasses were most often to the popliteal artery (81.2%); however, in 18.8% of cases, bypasses were to tibial targets. Suprainguinal bypasses originated primarily from the abdominal aorta (88.6%) but also from the axillary artery (10.6%) and thoracic aorta (0.8%). Common perioperative complications were access site hematoma in 4.9% of PVIs and cardiac complications in 3.7% of infrainguinal bypasses and 11.3% of suprainguinal bypasses. Overall, 30-day mortality was 0.4% to 2%. After 1 year, of patients initially ambulating without assistance, 2.4% to 3.6% required assistance and 0.3% to 1.3% were nonambulatory. Ipsilateral reintervention/amputation-free survival, major amputation-free survival, and survival at 1 year were 81.4% to 90.6%, 92.9% to 94.1%, and 95.3% to 97%, respectively. CONCLUSIONS: Multisegment PVI was the most commonly performed intervention for claudication; however, a subset of patients received treatments supported by limited evidence, including isolated tibial PVI and bypasses with axillary inflow and tibial outflow. Interventions had low perioperative morbidity and mortality, yet patients were still at risk for worse functional status and limb loss at 1 year, emphasizing the importance of careful patient selection, medical optimization, and informed consent.
引用
- Levin SR, Farber A, Cheng TW, et al. Patients undergoing interventions for claudication experience low perioperative morbidity but are at risk for worsening functional status and limb loss. J Vasc Surg. 2019. PMID: 31839346. doi:10.1016/j.jvs.2019.08.278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。